Implementation of patient-reported outcomes in routine medical care

G VELIKOVA - American Society of Clinical Oncology Educational …, 2018 - ascopubs.org
There is increasing interest to integrate collection of patient-reported outcomes (PROs) in
routine practice to enhance clinical care. Multiple studies show that systematic monitoring of …

[HTML][HTML] Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis

M Al Maqbali, M Al Sinani, Z Al Naamani… - Journal of pain and …, 2021 - Elsevier
Context Fatigue is a particularly common and troubling symptom that has a negative impact
on quality of life throughout all phases of treatment and stages of the illness among patients …

[HTML][HTML] The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline

M Di Maio, E Basch, F Denis, LJ Fallowfield, PA Ganz… - Annals of …, 2022 - Elsevier
Highlights•This ESMO Guideline provides key recommendations on the role of PROMs
during the care of patients with cancer.•It covers the use of PROMs in patients with cancer …

Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy

K Absolom, L Warrington, E Hudson… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Electronic patient self-Reporting of Adverse-events: Patient Information and
aDvice (eRAPID) is an online eHealth system for patients to self-report symptoms during …

[HTML][HTML] Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research

JM Giesinger, FLC Loth, NK Aaronson… - Journal of clinical …, 2020 - Elsevier
Objective The objective of this study was to establish thresholds for clinical importance
(TCIs) for the five functioning and nine symptom scales of the European Organisation for …

[PDF][PDF] Validity and reliability of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO …

AC Dueck, TR Mendoza, SA Mitchell, BB Reeve… - JAMA …, 2015 - jamanetwork.com
Importance To integrate the patient perspective into adverse event reporting, the National
Cancer Institute developed a patient-reported outcomes version of the Common …

Safety and tolerability of PD‐1/PD‐L1 inhibitors compared with chemotherapy in patients with advanced cancer: a meta‐analysis

TF Nishijima, SS Shachar, KA Nyrop, HB Muss - The oncologist, 2017 - academic.oup.com
Background Compared with chemotherapy, significant improvement in survival outcomes
with the programmed death receptor‐1 (PD‐1) inhibitors nivolumab and pembrolizumab and …

Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms

PG Kluetz, A Slagle, EJ Papadopoulos… - Clinical Cancer …, 2016 - AACR
Cancer clinical trials have relied on overall survival and measures of tumor growth or
reduction to assess the efficacy of a drug. However, benefits are often accompanied by …

Composite grading algorithm for the national cancer institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

E Basch, C Becker, LJ Rogak, D Schrag… - Clinical …, 2021 - journals.sagepub.com
Background: The Patient-Reported Outcomes version of the Common Terminology Criteria
for Adverse Events is an item library designed for eliciting patient-reported adverse events in …

Patient-reported outcomes in the evaluation of toxicity of anticancer treatments

M Di Maio, E Basch, J Bryce, F Perrone - Nature reviews Clinical …, 2016 - nature.com
Symptomatic toxicities associated with anticancer treatments, such as nausea and vomiting,
are frequently underreported by clinicians, even when data are prospectively collected …